Sana Biotechnology (SANA) Stock Statistics & Valuation Metrics

Sana Biotechnology has a market cap or net worth of $575.17M. The enterprise value is ―.

Sana Biotechnology has 225,555,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sana Biotechnology’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -58.26%.

The current PE Ratio of Sana Biotechnology is -1.41. Sana Biotechnology’s PEG ratio is -0.09.

In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -266.76M in profits. Earnings per share was -1.16.

In the last 12 months, operating cash flow was -223.15M and capital expenditures -33.43M, giving a free cash flow of -256.58M billion.

Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Sana Biotechnology upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Sana Biotechnology as a current ratio of 3.54, with Debt / Equity ratio of 37.60%

In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.

Sana Biotechnology EV to EBITDA ratio is -1.26, with an EV/FCF ratio of -1.34.

Sana Biotechnology has $152.50M in cash and marketable securities with $94.20M in debt, giving a net cash position of -$58.30M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sana Biotechnology is $7.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy